Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT05496556
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of stage IV non-small cell lung carcinoma with indication for first-line systemic treatment (chemotherapy, immunotherapy or specific treatment, in particular tyrosine kinase inhibitors) according to current French recommendations.
* Age over 18 and under 70
* Patient speaking and reading French fluently
* Affiliation to a social security scheme
* Patient able and willing to follow all study procedures in accordance with the protocol
* Patient having understood, signed and dated the consent form
Exclusion Criteria:
* Patient requiring hospitalization for more than 48 hours for the administration of the first course of treatment
* Patient benefiting from antibiotic therapy for the treatment of an acute infection
* Psychiatric, cognitive or neurological disorders making it impossible to assess food preferences and/or any impossibility to undergo medical monitoring for the trial for geographical, social or psychological reasons.
* Daily alcohol consumption
* Chest radiotherapy treatment
* Pregnant woman, likely to be, or breastfeeding
* Persons deprived of liberty or under guardianship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05496556
Study Brief:
Protocol Section:
NCT05496556